Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Terminated

Clerio Vision, extreme H2O monthly, MED, DIA 14.0 PWR -2.25, UPC 675506803334 (6 count) and UPC 675506804478 (12 count) - Product Usage: for daily wear is indicated for the correction of visual acuity in aphakic or not-aphakic persons with non-diseased eyes that are myopic or hyperopic. The lens may be worn by persons who exhibit astigmatism of 0.75 Diopters or less that does not interfere with visual acuity.

FDA Recall Z-0808-2021 · Posted None

Recalling FirmClerio Vision
Recall StatusTerminated
Product CodeLPL
Date Initiated2020-12-10
Date Terminated2023-07-05
Product Quantity208 lenses

Reason for Recall

One lot of contact lenses labeled as BC MED, DIA 14.0 PWR -2.25 contained BC MED, DIA 14.0, PWR -3.75 contact lenses

Firm Action

The firm initiated the recall by letter and email on 12/10/2020. The letter requested the following actions to be taken by the customer: "Distributors: Please immediately examine your inventory, cease all distribution and quarantine this product. Please complete the response form at the end of this notice and return by email to [email protected] even if you no longer have any of the product. Return any inventory via US Mail, marking the package, Attention: Returns Department Recall Product. Your account will be reimbursed for the returned goods and shipping cost. If you have further distributed this product, please identify your customers and notify them at once of this product recall. You may include this letter in your notification, or you can provide us with your customer list and we will notify them. Physicians/Opticians/Retailers: Please complete the response form at the end of this notice and return by email to [email protected] even if you no longer have any of the product. Return any inventory via US Mail, marking the package, Attention: Returns Department Recall Product. Your account will be reimbursed for the returned goods and shipping cost. If you have dispensed this product, please identify your patients/customers and notify them at once of this product recall. You may include this letter in your notification."

Root Cause

Process control

Distribution Pattern

US Nationwide distribution.

Official Source

View FDA Recall →

Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.

↑